RY

Rao Yakkali Ramasubba

Active Director Director DIN 09619994
DIN 09619994 First appointment May 2022 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rao Yakkali Ramasubba

Data last updated:

Rao Yakkali Ramasubba is a Director at Avin Mednologies Private Limited (since 2022). The company operates in Information Technology.

DIN 09619994
Primary Designation Director
Industry Information Technology
First Appointment 25 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avin Mednologies Private Limited U72900TG2022PTC163073
Director25 May 20222022Active

Board colleagues of Rao Yakkali Ramasubba

Directorship timeline

Open interactive timeline →
Avin Mednologies Private Limited
Premium access

Shareholding and investment profile for Rao Yakkali Ramasubba

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rao Yakkali Ramasubba

Rao Yakkali Ramasubba currently holds 1 directorship: Avin Mednologies Private Limited (Director, since 25 May 2022).

Rao Yakkali Ramasubba was first appointed on 25 May 2022 as Director at Avin Mednologies Private Limited.

The current boards of Rao Yakkali Ramasubba's companies include Avinash Yakkali (Avin Mednologies Private Limited), Lalitha Devi Yakkali (Avin Mednologies Private Limited), Santaluri Raghu Datta (Avin Mednologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available